Skip to main content
. Author manuscript; available in PMC: 2018 Apr 30.
Published in final edited form as: Sci Signal. 2017 Oct 31;10(503):eaan1011. doi: 10.1126/scisignal.aan1011

Figure 2. UAS-GFP reporter output increased in hematopoietic cells following GCSF and PHZ treatment.

Figure 2

(A) mCherry and GFP intensity in whole bone marrow cells from recipient mice that were transplanted as in Fig. 1A and then treated with or without bexarotene, GCSF, or phenylhydrazine (PHZ). (B and C) Summary results of the ratio of GFP+mCherry+ cells to total mCherry+ cells (B) or mean fluorescence intensity (MFI) (C) in whole bone marrow cells from recipient mice transplanted with UAS-GFP Kit+ bone marrow cells transduced with Gal4-RXRA; N = 21 (Gal4-RXRA recipient mice without treatment), 9 (Gal4-RXRA recipient mice treated with bexarotene), 11 (Gal4-RXRA recipient mice treated with GCSF), 10 (Gal4-RXRA recipient mice treated with PHZ). Error bars represent standard deviation between individual recipient mice. * P < 0.05, *** P < 0.001, ANOVA with Tukey’s multiple comparison test.